IRIS Accounts Production v25.2.0.378 05295606 director 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 05295606 2024-03-31 05295606 2025-03-31 05295606 2024-04-01 2025-03-31 05295606 2023-03-31 05295606 2023-04-01 2024-03-31 05295606 2024-03-31 05295606 ns15:EnglandWales 2024-04-01 2025-03-31 05295606 ns14:PoundSterling 2024-04-01 2025-03-31 05295606 ns10:Director1 2024-04-01 2025-03-31 05295606 ns10:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 05295606 ns10:SmallEntities 2024-04-01 2025-03-31 05295606 ns10:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 05295606 ns10:SmallCompaniesRegimeForDirectorsReport 2024-04-01 2025-03-31 05295606 ns10:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 05295606 ns10:FullAccounts 2024-04-01 2025-03-31 05295606 ns10:RegisteredOffice 2024-04-01 2025-03-31 05295606 ns5:CurrentFinancialInstruments 2025-03-31 05295606 ns5:CurrentFinancialInstruments 2024-03-31 05295606 ns5:ShareCapital 2025-03-31 05295606 ns5:ShareCapital 2024-03-31 05295606 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 05295606 ns5:RetainedEarningsAccumulatedLosses 2024-03-31 05295606 ns5:PlantMachinery 2024-04-01 2025-03-31 05295606 ns5:PlantMachinery 2024-03-31 05295606 ns5:PlantMachinery 2025-03-31 05295606 ns5:PlantMachinery 2024-03-31 05295606 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-03-31 05295606 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-03-31

REGISTERED NUMBER: 05295606 (England and Wales)

| UNAUDITED FINANCIAL STATEMENTS |

| FOR THE YEAR ENDED 31 MARCH 2025 |

| FOR |

| CORENZA MEDICAL SERVICES LIMITED |

CORENZA MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05295606)

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 3 |

CORENZA MEDICAL SERVICES LIMITED

COMPANY INFORMATION

FOR THE YEAR ENDED 31 MARCH 2025

| DIRECTOR: | S Poole

| REGISTERED OFFICE: | 27 Denmark Avenue

| 11 Wellesley House

| Wimbledon

| London

| SW19 4HQ

| REGISTERED NUMBER: | 05295606 (England and Wales)

| ACCOUNTANTS: | Hartley Fowler LLP

| Chartered Accountants

| 4th Floor Tuition House

| 27-37 St George's Road

| Wimbledon

| London

| SW19 4EU

CORENZA MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05295606)

BALANCE SHEET

31 MARCH 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 6,188 |  | 6,902 |  |

CURRENT ASSETS

Debtors | 5 | 18,851 |  | 5,211 |  |

Cash at bank and in hand | 9,241 |  | 20,578 |  |

28,092 |  | 25,789 |  |

CREDITORS

Amounts falling due within one year | 6 | 15,066 |  | 18,974 |  |

NET CURRENT ASSETS | 13,026 |  | 6,815 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 19,214 |  | 13,717 |  |

CAPITAL AND RESERVES

Called up share capital | 1 |  | 1 |  |

Retained earnings | 19,213 |  | 13,716 |  |

SHAREHOLDERS' FUNDS | 19,214 |  | 13,717 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 18 August 2025 and were signed by:

S Poole - Director

CORENZA MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05295606)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

1. | STATUTORY INFORMATION

| Corenza Medical Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Revenue is measured at fair value of the consideration received or receivable. Revenue from services is recognised when the service is provided and the right to consideration earned. To the extent that a service is provided to third parties but no billing made, the amount is recognised as revenue and recorded as accrued income.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Plant and machinery | - | 25% on cost and 25% on reducing balance

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

| Debtors and creditors receivable/ payable within one year

| Debtors and creditors with no stated interest rate and receivables or payables within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

CORENZA MEDICAL SERVICES LIMITED (REGISTERED NUMBER: 05295606)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 MARCH 2025

2. | ACCOUNTING POLICIES - continued

| Impairment

| Assets not measured at fair value are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, or the asset's cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in profit or loss unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 1 (2024 - 1 ) .

4. | TANGIBLE FIXED ASSETS

| Plant and

| machinery

| etc

£ |

| COST

| At 1 April 2024 | 30,236 |  |

| Additions | 1,269 |  |

| At 31 March 2025 | 31,505 |  |

| DEPRECIATION

| At 1 April 2024 | 23,334 |  |

| Charge for year | 1,983 |  |

| At 31 March 2025 | 25,317 |  |

| NET BOOK VALUE

| At 31 March 2025 | 6,188 |  |

| At 31 March 2024 | 6,902 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Other debtors | 18,851 |  | 5,211 |  |

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Taxation and social security | 12,426 |  | 16,334 |  |

| Other creditors | 2,640 |  | 2,640 |  |

15,066 |  | 18,974 |  |

7. | DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

| At the balance sheet date the company was owed £17,051 (2024: £2,367) by the director in respect of her director's loan account. The loan account is repayable on demand and bears interest.